We're maintaining the world's largest resposity of hair loss
research. You can help out the community by
sending a PDF of this study here
.
Not sure how to get a study's PDF? You can email the authors
of the study.
The conversation is about using valproic acid, an anti-seizure medication, as a topical treatment to promote hair growth. The original poster is seeking personal experiences from those who have tried this method.
The conversation is about using PTD-DBM and valproic acid for hairloss. The user is inquiring about the dosage of these treatments, noting that valproic acid is used at a 7.5% solution.
Topical sodium valproate may promote hair growth by inhibiting GSK3β, allowing beta-catenin to proliferate, but it has potential side effects and requires more research. The conversation also mentions skepticism about a product called Vdphlo1, which includes sodium valproate and other ingredients.
The conversation is about someone experiencing continued hairloss despite using Pyrilutamide and considering the need for more time or better quality control for the treatment. Another person suggests waiting for the drug to be officially approved due to potential quality issues with current products.
The conversation is about using topical valproic acid (VPA) for hairloss, focusing on its application method, usage frequency, and combination with other treatments like micro-needling. No specific experiences with VPA were shared.
How Pyrilutamide, a hairloss treatment, has improved texture and regrowth of hair without any side effects for users, who are encouraged to post progress photos.